Clinical Trial Update: A Study to Evaluate the Efficacy of Lenalidomide as Maintenance Therapy After Completion of First-line Combination Chemotherapy in Patients With Mantle Cell Lymphoma (MCL). [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating lenalidomide as maintenance therapy after first-line chemotherapy in mantle cell lymphoma; the study was terminated with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: Celgene | Conditions: Mantle Cell Lymphoma, Non-Hodgkin's Lymphoma | Phase 3 | Status: TERMINATED | Results posted: 2011-12-02